US Stock MarketDetailed Quotes

BEAM Beam Therapeutics

Watchlist
  • 22.930
  • +1.020+4.66%
Close Nov 1 16:00 ET
  • 22.930
  • 0.0000.00%
Post 20:02 ET
1.89BMarket Cap-14154P/E (TTM)

Beam Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
1.96%-83.01M
9.17%-99.75M
-762.29%-149.2M
295.22%135.07M
-20.52%-89.78M
-61.97%-84.67M
-150.26%-109.82M
133.99%22.53M
-3,880.93%-69.19M
-2,577.42%-74.5M
Net income from continuing operations
-10.00%-91.05M
-2.29%-98.67M
54.16%-132.53M
472.36%142.8M
12.31%-96.09M
-15.05%-82.78M
-39.36%-96.46M
22.00%-289.09M
40.73%-38.35M
-289.70%-109.58M
Operating gains losses
-711.11%-5.5M
151.79%2.9M
-568.75%-7.5M
163.33%1.9M
-115.46%-4.7M
107.38%900K
58.82%-5.6M
60.00%1.6M
59.46%-3M
184.92%30.4M
Depreciation and amortization
15.78%5.58M
16.87%5.43M
41.46%20.01M
35.95%5.36M
49.35%5.19M
40.90%4.82M
40.31%4.65M
89.87%14.15M
49.73%3.94M
98.46%3.47M
Other non cash items
102.30%615K
-5.89%2.49M
97.89%-221K
103.12%539K
-223.06%-3.71M
-86.29%304K
71.19%2.65M
-106.59%-10.47M
-360.79%-17.25M
135.71%3.02M
Change In working capital
-26.59%-25.91M
15.33%-37.96M
-146.28%-116.46M
-204.42%-31.51M
-89.35%-19.64M
-1,753.47%-20.47M
-116.54%-44.83M
126.17%251.63M
-123.02%-10.35M
-118.59%-10.37M
-Change in receivables
----
----
-100.05%-146K
---146K
----
----
----
200.00%300M
--0
--0
-Change in prepaid assets
223.79%6.25M
34.18%-5.53M
16.51%-6.47M
736.36%3.57M
-1,417.87%-3.57M
-13.42%1.93M
8.49%-8.41M
-1,139.28%-7.75M
-4,415.38%-561K
-106.12%-235K
-Change in payables and accrued expense
-532.64%-17.71M
-127.20%-22.99M
512.67%60.09M
505.07%68.63M
-4.17%4.37M
77.92%-2.8M
43.10%-10.12M
-132.55%-14.56M
-73.78%11.34M
926.27%4.56M
-Change in other current assets
----
----
--0
----
----
----
----
--0
----
----
-Change in other current liabilities
-556.94%-3.17M
2.81%-2.53M
-205.08%-10.36M
-267.15%-4.02M
-395.73%-3.25M
-114.46%-483K
-139.93%-2.6M
-44.65%9.86M
-139.68%-1.1M
-66.35%1.1M
-Change in other working capital
41.03%-11.27M
70.85%-6.91M
-344.21%-159.56M
-396.80%-99.54M
-8.82%-17.19M
-328.99%-19.12M
-181.17%-23.71M
-110.32%-35.92M
-106.70%-20.04M
-1,967.93%-15.8M
Cash from discontinued investing activities
Operating cash flow
1.96%-83.01M
9.17%-99.75M
-762.29%-149.2M
295.22%135.07M
-20.52%-89.78M
-61.97%-84.67M
-150.26%-109.82M
133.99%22.53M
-3,880.93%-69.19M
-2,577.42%-74.5M
Investing cash flow
Cash flow from continuing investing activities
310.93%87.49M
-310.07%-53.46M
115.57%71.84M
-13.52%98.1M
71.72%-10.23M
-3,186.85%-41.48M
104.74%25.45M
-56.84%-461.34M
246.38%113.44M
-147.53%-36.17M
Net PPE purchase and sale
87.88%-1.96M
59.48%-2.44M
31.09%-33.73M
56.55%-3.59M
32.57%-7.95M
25.25%-16.18M
17.11%-6.02M
-4.57%-48.95M
38.21%-8.26M
-103.93%-11.79M
Net business purchase and sale
----
----
--0
----
----
----
----
--0
----
----
Net investment purchase and sale
453.55%89.45M
-262.15%-51.03M
125.60%105.57M
-16.44%101.69M
90.64%-2.28M
-224.14%-25.3M
105.94%31.47M
-66.32%-412.39M
289.78%121.7M
-129.78%-24.39M
Cash from discontinued investing activities
Investing cash flow
310.93%87.49M
-310.07%-53.46M
115.57%71.84M
-13.52%98.1M
71.72%-10.23M
-3,186.85%-41.48M
104.74%25.45M
-56.84%-461.34M
246.38%113.44M
-147.53%-36.17M
Financing cash flow
Cash flow from continuing financing activities
-99.88%133K
-97.06%2.9M
147.74%276.45M
5.31%33.71M
2,254.48%36.78M
381.39%107.54M
76.77%98.42M
-85.24%111.59M
48.60%32.01M
-99.51%1.56M
Net issuance payments of debt
82.66%-107K
70.65%-177K
1.53%-2.25M
-7.12%-632K
30.92%-400K
-9.20%-617K
-9.04%-603K
-7.98%-2.29M
-8.86%-590K
-9.25%-579K
Net common stock issuance
--0
--0
149.56%270.17M
5.35%33.6M
--34.95M
381.36%107.64M
74.03%93.98M
-85.71%108.26M
57.54%31.89M
--0
Proceeds from stock option exercised by employees
-65.81%240K
-39.73%3.07M
57.79%9.16M
-2.36%745K
20.78%2.62M
8.67%702K
128.49%5.1M
-39.67%5.81M
-61.25%763K
-19.84%2.17M
Net other financing activities
----
----
-235.64%-631K
--0
-1,436.00%-384K
-79.61%-185K
-933.33%-62K
97.87%-188K
57.81%-54K
88.04%-25K
Cash from discontinued financing activities
Financing cash flow
-99.88%133K
-97.06%2.9M
147.74%276.45M
5.31%33.71M
2,254.48%36.78M
381.39%107.54M
76.77%98.42M
-85.24%111.59M
48.60%32.01M
-99.51%1.56M
Net cash flow
Beginning cash position
13.38%294.3M
81.09%444.61M
-57.13%245.52M
5.00%177.73M
-13.44%240.97M
-16.15%259.57M
-57.13%245.52M
223.56%572.74M
-73.00%169.26M
22.71%278.37M
Current changes in cash
124.81%4.62M
-1,169.70%-150.31M
160.84%199.09M
249.97%266.89M
42.04%-63.24M
40.36%-18.61M
105.34%14.05M
-182.69%-327.22M
240.90%76.26M
-127.28%-109.11M
End cash Position
24.05%298.92M
13.38%294.3M
81.09%444.61M
81.09%444.61M
5.00%177.73M
-13.44%240.97M
-16.15%259.57M
-57.13%245.52M
-57.13%245.52M
-73.00%169.26M
Free cash flow
15.74%-84.97M
11.78%-102.19M
-592.28%-182.93M
269.76%131.48M
-13.27%-97.73M
-36.43%-100.85M
-154.84%-115.83M
76.63%-26.42M
-571.22%-77.45M
-3,011.54%-86.28M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 1.96%-83.01M9.17%-99.75M-762.29%-149.2M295.22%135.07M-20.52%-89.78M-61.97%-84.67M-150.26%-109.82M133.99%22.53M-3,880.93%-69.19M-2,577.42%-74.5M
Net income from continuing operations -10.00%-91.05M-2.29%-98.67M54.16%-132.53M472.36%142.8M12.31%-96.09M-15.05%-82.78M-39.36%-96.46M22.00%-289.09M40.73%-38.35M-289.70%-109.58M
Operating gains losses -711.11%-5.5M151.79%2.9M-568.75%-7.5M163.33%1.9M-115.46%-4.7M107.38%900K58.82%-5.6M60.00%1.6M59.46%-3M184.92%30.4M
Depreciation and amortization 15.78%5.58M16.87%5.43M41.46%20.01M35.95%5.36M49.35%5.19M40.90%4.82M40.31%4.65M89.87%14.15M49.73%3.94M98.46%3.47M
Other non cash items 102.30%615K-5.89%2.49M97.89%-221K103.12%539K-223.06%-3.71M-86.29%304K71.19%2.65M-106.59%-10.47M-360.79%-17.25M135.71%3.02M
Change In working capital -26.59%-25.91M15.33%-37.96M-146.28%-116.46M-204.42%-31.51M-89.35%-19.64M-1,753.47%-20.47M-116.54%-44.83M126.17%251.63M-123.02%-10.35M-118.59%-10.37M
-Change in receivables ---------100.05%-146K---146K------------200.00%300M--0--0
-Change in prepaid assets 223.79%6.25M34.18%-5.53M16.51%-6.47M736.36%3.57M-1,417.87%-3.57M-13.42%1.93M8.49%-8.41M-1,139.28%-7.75M-4,415.38%-561K-106.12%-235K
-Change in payables and accrued expense -532.64%-17.71M-127.20%-22.99M512.67%60.09M505.07%68.63M-4.17%4.37M77.92%-2.8M43.10%-10.12M-132.55%-14.56M-73.78%11.34M926.27%4.56M
-Change in other current assets ----------0------------------0--------
-Change in other current liabilities -556.94%-3.17M2.81%-2.53M-205.08%-10.36M-267.15%-4.02M-395.73%-3.25M-114.46%-483K-139.93%-2.6M-44.65%9.86M-139.68%-1.1M-66.35%1.1M
-Change in other working capital 41.03%-11.27M70.85%-6.91M-344.21%-159.56M-396.80%-99.54M-8.82%-17.19M-328.99%-19.12M-181.17%-23.71M-110.32%-35.92M-106.70%-20.04M-1,967.93%-15.8M
Cash from discontinued investing activities
Operating cash flow 1.96%-83.01M9.17%-99.75M-762.29%-149.2M295.22%135.07M-20.52%-89.78M-61.97%-84.67M-150.26%-109.82M133.99%22.53M-3,880.93%-69.19M-2,577.42%-74.5M
Investing cash flow
Cash flow from continuing investing activities 310.93%87.49M-310.07%-53.46M115.57%71.84M-13.52%98.1M71.72%-10.23M-3,186.85%-41.48M104.74%25.45M-56.84%-461.34M246.38%113.44M-147.53%-36.17M
Net PPE purchase and sale 87.88%-1.96M59.48%-2.44M31.09%-33.73M56.55%-3.59M32.57%-7.95M25.25%-16.18M17.11%-6.02M-4.57%-48.95M38.21%-8.26M-103.93%-11.79M
Net business purchase and sale ----------0------------------0--------
Net investment purchase and sale 453.55%89.45M-262.15%-51.03M125.60%105.57M-16.44%101.69M90.64%-2.28M-224.14%-25.3M105.94%31.47M-66.32%-412.39M289.78%121.7M-129.78%-24.39M
Cash from discontinued investing activities
Investing cash flow 310.93%87.49M-310.07%-53.46M115.57%71.84M-13.52%98.1M71.72%-10.23M-3,186.85%-41.48M104.74%25.45M-56.84%-461.34M246.38%113.44M-147.53%-36.17M
Financing cash flow
Cash flow from continuing financing activities -99.88%133K-97.06%2.9M147.74%276.45M5.31%33.71M2,254.48%36.78M381.39%107.54M76.77%98.42M-85.24%111.59M48.60%32.01M-99.51%1.56M
Net issuance payments of debt 82.66%-107K70.65%-177K1.53%-2.25M-7.12%-632K30.92%-400K-9.20%-617K-9.04%-603K-7.98%-2.29M-8.86%-590K-9.25%-579K
Net common stock issuance --0--0149.56%270.17M5.35%33.6M--34.95M381.36%107.64M74.03%93.98M-85.71%108.26M57.54%31.89M--0
Proceeds from stock option exercised by employees -65.81%240K-39.73%3.07M57.79%9.16M-2.36%745K20.78%2.62M8.67%702K128.49%5.1M-39.67%5.81M-61.25%763K-19.84%2.17M
Net other financing activities ---------235.64%-631K--0-1,436.00%-384K-79.61%-185K-933.33%-62K97.87%-188K57.81%-54K88.04%-25K
Cash from discontinued financing activities
Financing cash flow -99.88%133K-97.06%2.9M147.74%276.45M5.31%33.71M2,254.48%36.78M381.39%107.54M76.77%98.42M-85.24%111.59M48.60%32.01M-99.51%1.56M
Net cash flow
Beginning cash position 13.38%294.3M81.09%444.61M-57.13%245.52M5.00%177.73M-13.44%240.97M-16.15%259.57M-57.13%245.52M223.56%572.74M-73.00%169.26M22.71%278.37M
Current changes in cash 124.81%4.62M-1,169.70%-150.31M160.84%199.09M249.97%266.89M42.04%-63.24M40.36%-18.61M105.34%14.05M-182.69%-327.22M240.90%76.26M-127.28%-109.11M
End cash Position 24.05%298.92M13.38%294.3M81.09%444.61M81.09%444.61M5.00%177.73M-13.44%240.97M-16.15%259.57M-57.13%245.52M-57.13%245.52M-73.00%169.26M
Free cash flow 15.74%-84.97M11.78%-102.19M-592.28%-182.93M269.76%131.48M-13.27%-97.73M-36.43%-100.85M-154.84%-115.83M76.63%-26.42M-571.22%-77.45M-3,011.54%-86.28M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --------------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Gene Editing
Gene Editing
Intraday+0.75%
ARK Portfolio
ARK Portfolio
Intraday+0.14%